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Introduction
-

-

Exercise-induced bronchoconstriction (EIB),
formerly exercise-induced asthma, has a
prevalence of 5-20% in the general
population and may affect up to 90% of
patients with symptomatic asthma.
Presents as shortness of breath, chest
tightness, and cough 10-15 minutes after
initiation of exercise with a 4 hour latency
period after symptoms

Data for EVH
Eucapnic Voluntary Hyperventilation (EVH)
-

Pathophysiology thought to be related to
dramatic increases in minute ventilation of
large volume cool, dry air, leading to
bronchospasm

-

-

EIB is typically diagnosed and treated
based on symptoms alone

-

-

However, not all patients with these
symptoms have EIB, and alternative
diagnoses such as exercise-induced vocal
cord dysfunction (EIVCD) are difficult to
differentiate without objective testing

-

-

EVH is a bronchoprovocation test, which stimulates exercise
while maintaining patient CO2 levels
Baseline spirometry followed by breathing the test gas mixture
(5% CO2, 74% N, 21% O2) at a target minute ventilation (30 x
FEV1) for 6 minutes
Spirometry is then performed at 3, 5, 10, 15, and 20 minute
time points following simulated exercise
EVH is diagnostic if average maximum voluntary ventilation
per minute (MVV) is >60%
A positive test is defined as a >10% decrease in any post-EVH
FEV1

Image 2:EVH
Apparatus [6]

Case Presentation
-

42 yo F with no significant medical history,
presented with dyspnea and chest
tightness, starting 20-30 minutes into
running exercise, resolved with rest

-

Symptoms started 5 years ago

-

Given an albuterol inhaler and later
montelukast by her PCP, without
improvement

-

Referred to pulmonology and underwent
EVH testing

-

Test was sufficient, but
negative for EIB (postEVH FEV1 <10).

-

However, the inspiratory
limb of her post-exercise
flow volume loop was
flattened (Image 1)

-

Referred to ENT for VLS

-

VLS showed paradoxical vocal cord function
with rapid and forced breathing
She was diagnosed with exercise-induced
vocal cord dysfunction (EIVCD)

-

She underwent outpatient speech language
therapy with significant improvement

EVH was first used at Walter Reed Army
Medical Center in 1985

-

The results were reproducible and
consistent on repeat EVH evaluations [7]

-

A standardized protocol was created in
2001 by Anderson et al. [6]

-

EVH has been compared against exercise
testing and methacholine challenge tests
with similar NPV and superior PPV [2, 9]

-

EVH is now considered the gold standard of
EIB diagnosis [3]

-

Patients with EIB without asthma had higher
inflammatory mediators in sputum following
a (+) EVH, than EVH negative patients [8]

-

Multiple studies have shown a correlation
between inspiratory flow volume loop
flattening and vocal cord dysfunction, later
found on VLS [4, 5]

Discussion
-

Patients presenting with symptoms
consistent with EIB should be considered
for objective testing with EVH, especially if
failing first line therapy

-

EVH has been well studied in elite athletes
and academic centers, and is being
increasingly utilized in community settings

-

EVH can also show inspiratory flow volume
loop abnormalities, which are suggestive
alternative conditions such as EIVCD

-

EIVCD is treated with speech therapy, as
opposed to bronchodilators for EIB

-

Utilization of EVH can likely decrease
inappropriate medication use and
healthcare utilization and increase accuracy
of treatment

Treatment Algorithm for EIB

Image 1: FV loop at 5 min

-

-

Algorithm 1: Diagnostic and
Treatment Approach to EIB

-

EIVCD = Exercise-induced vocal cord dysfunction
SABA = Short-acting B2 agonist
LABA = Long-acting B2 agonist
ICS = Inhaled corticosteroid
LTRA = Leukotriene receptor antagonist
Adapted and modified from the 2012 ATS guidelines
for exercise-induced bronchoconstriction [1]
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